课题基金 / 基金详情

Combined effects of differentiation-apoptosis inducers on mice inoculated with human leukemia cells.

Combined effects of differentiation-apoptosis inducers on mice inoculated with human leukemia cells.
分化-凋亡诱导剂对接种人白血病细胞的小鼠的综合作用。
批准号:
06672239
负责人:
NAKAYA Kazuyasu
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

NAKAYA Kazuyasu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have found that geranylgeraniol (GGO) is a potent inducer of apoptosis in various tumor cell lines including human myeloid leukemia, lymphoblastic, and adenocarcinoma. Upon treatment of HL-60 cells with 50 muM GGO, 85% of DNA was fragmented in 3 h. [^3H] GGO was taken up by HL-60 cells in 3 h and was incorporated into several proteins with molecular masses from 10.5 to 20.1 kDa, suggesting these proteins were geranylgeranylated. The expression of c-myc and bc1-2 decreased significantly within 3 h.To explore agents for differentiation-apoptosis therapy of leukemia, various combinations of differentiation-and apoptosis-inducers were examined for the strongest apoptosis-inducing activity for human HL-60 cells. The strongest apotosis-inducing acitvity on HL-60 cells were obtained by combining with retinoic acid, bufalin, and VP16. Administration of the combination of retinoic acid, bufalin, and VP16 to mice inoculated with HL-60 cells was makedly effective in prolongation of survival.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Hidekazu OHIZUMI: "Geranylgeraniol is a potent inducer of apoptosis in tumor cells." J. Biochem.117. 11-13 (1995)
Hidekazu OHIZUMI:“香叶基香叶醇是肿瘤细胞凋亡的有效诱导剂。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Itaru SAKAI: "Novel role vitmin K2 : a potent inducer of differentiaionof various human myeloid leukemia cell lines" Biochem. Biophys. Res. Commun.205. 1305-1310 (1994)
Itaru SAKAI:“维生素 K2 的新作用:多种人类骨髓性白血病细胞系分化的有效诱导剂”Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hidekazu OHIZUMI: "Geranylgeraniol is a potent inducer of apoptosis in tumor cells." J.Biochem.117. 11-13 (1995)
Hidekazu OHIZUMI:“香叶基香叶醇是肿瘤细胞凋亡的有效诱导剂。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Itaru Sakai, Schiko Hashimoto, Madoka Yoda, Takayuki Hida, Shigemitsu Osawa, Shigeo Nakajo and kazuyasu Nakaya: "Role of vitamin K2 ; a potent inducer of differentiation of various human myeloid leukemia cell lines" Biochem.Biophys.Res.Commun.205. 1305-13
Itaru Sakai、Schiko Hashimoto、Madoka Yoda、Takayuki Hida、Shigemitsu Osawa、Shigeo Nakajo 和 kazuyasu Nakaya:“维生素 K2 的作用;各种人类骨髓性白血病细胞系分化的有效诱导剂”Biochem.Biophys.Res.Commun.205。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    High resolution analysis of proteins associated with the induction of cell death and carcinogenesis of tumor cells development of chemopreventive agents
    Development of a novel anti-cancer agent from a novel tyrosine kinase inhibitor
    • 批准号:
      13672297
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      NAKAYA Kazuyasu
    • 依托单位:
    Studies on apoptosis-inducers targeted for the molecules associated with the induction of apoptosis in cancer cells
    • 批准号:
      11672182
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1999
    • 负责人:
      NAKAYA Kazuyasu
    • 依托单位:
    Effects of isoprenoid compounds on human solid cancer cells
    • 批准号:
      09672251
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1997
    • 负责人:
      NAKAYA Kazuyasu
    • 依托单位:
    国内基金
    海外基金
    Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
    • 批准号:
      82370979
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张善勇
    • 依托单位:
    BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
    • 批准号:
      82370801
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李峰
    • 依托单位:
    22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
    • 批准号:
      82370906
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      代杰文
    • 依托单位:
    新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
    • 批准号:
      82371711
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      吕志宝
    • 依托单位: